A study of lanabecestat (LY3314814) in healthy participants

Trial Identifier: 16001
Sponsor:AstraZeneca
Collaborator:
Eli Lilly and Company
NCTID:NCT02663128
Start Date:January 2016
Primary Completion Date: March 2016
Study Completion Date: March 2016
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

No locations posted.